Search
Descriptor English: BCG Vaccine
Descriptor Spanish: Vacuna BCG
Descriptor vacuna BCG
Entry term(s) vacuna de Calmette
vacuna del bacilo de Calmette-Guérin
Scope note: Preparado inmunizante activo y cepa atenuada no virulenta y viable de MYCOBACTERIUM BOVIS, que confiere inmunidad frente a las infecciones micobacterianas. Se utiliza también en la inmunoterapia de las neoplasias, debido a que estimula la producción de anticuerpos y la inmunidad inespecífica.
Descriptor Portuguese: Vacina BCG
Descriptor French: Vaccin BCG
Entry term(s): Bacillus Calmette Guerin Vaccine
Calmette Guerin Bacillus Vaccine
Calmette Vaccine
Calmette's Vaccine
Calmettes Vaccine
Vaccine, BCG
Vaccine, Calmette's
Tree number(s): D20.215.894.135.825.100
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D001500
Scope note: An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.
Annotation: BCG vaccination in prev of tuberc = BCG VACCINE (IM) + TUBERCULOSIS /prev (IM); BCG ther of various diseases = BCG VACCINE /ther use (IM) + dis /drug ther (IM)
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Adjuvants, Immunologic
Public MeSH Note: 1979; see TUBERCULOSIS VACCINES 1974-1978
History Note: 1979 (1974)
Related: Mycobacterium bovis MeSH
DeCS ID: 23093
Unique ID: D001500
NLM Classification: WF 250
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1979/01/01
Date of Entry: 1999/01/01
Revision Date: 2020/05/27
BCG Vaccine - Preferred
Concept UI M0002239
Scope note An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.
Preferred term BCG Vaccine
Entry term(s) Bacillus Calmette Guerin Vaccine
Calmette Guerin Bacillus Vaccine
Calmette Vaccine
Calmette's Vaccine
Calmettes Vaccine
Vaccine, BCG
Vaccine, Calmette's



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey